Data protection Impressum

Newsroom

Getting Serious

Best Of Getting Serious… So Far!

8 July 2026

Salesforce has announced plans to invest USD 1 billion in Switzerland over the next five years to accelerate the country's agentic AI transformation, in a commitment unveiled in Geneva ahead of the AI for Good Global Summit.

Salesforce to invest USD 1 billion in Switzerland’s AI transformation

8 July 2026

Neur.on, the Fribourg-based LegalTech behind the AI legal translation platform Corrext, has joined forces with Legal 230, Europe's leading legal translation network, while preserving Swiss data hosting and its Fribourg team.

Fribourg LegalTech Neur.on partners with European leader Legal 230

8 July 2026

In a world first, physicists at the University of Fribourg, with an international team, have used ultrafast light pulses to briefly create a topological state of matter in a semiconductor, confirming a theory formulated over a decade ago.

University of Fribourg physicists create a new state of matter with light pulses

8 July 2026

Carewell, a Lausanne-based start-up whose platform helps Swiss healthcare institutions manage staff shortages, has raised CHF 1.5 million in a seed round to accelerate its expansion across Switzerland.

Carewell raises CHF 1.5 million to manage healthcare staff shortages

6 July 2026

CCRAFT, a Neuchâtel-based CSEM spin-off operating the world's first independent foundry for thin-film lithium niobate photonic chips, has closed a USD 7.8 million funding round to build industrial-scale manufacturing capacity.

CCRAFT raises USD 7.8 million to scale up its photonic chip foundry

6 July 2026

LOXO, a Bern-based start-up developing a Level 4 autonomous driving solution for commercial vehicles, has entered a strategic partnership with US technology group DXC Technology, which includes an investment, to industrialize autonomous logistics.

LOXO secures DXC investment to scale its autonomous logistics technology

6 July 2026

Geneva has been named European Capital of Brain Health 2026 by the European Academy of Neurology, in recognition of its research and innovation ecosystem.

Geneva named European Capital of Brain Health 2026

6 July 2026

AC Immune will receive a USD 4 million research grant from The Vijay and Marie Goradia Charitable Foundation to extend Part 1 of the Phase 2 VacSYn trial of ACI-7104, its immunotherapy for early Parkinson's disease.

AC Immune secures USD 4 million grant to advance its Parkinson’s immunotherapy

6 July 2026

Top Stories Western Switzerland

Top Stories from Western Switzerland (June 2026)

29 June 2026

1 2 3 4 5 … 93